Levels of Lymphocyte Subpopulations in Peripheral Blood among Patients with Diabetes

1. Damoiseaux JG, Tervaert JW. The definition of autoimmune disease: are Koch’s postulates applicable? Neth J Med, 2002, 60:266-268.Search in Google Scholar

2. Wållberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol, 2013, 34, 583-591.10.1016/j.it.2013.08.005Search in Google Scholar

3. Wentworth JM, Fourlanos S, Harrison LC. Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat Rev Endocrinol, 2009, 5, 483-489.10.1038/nrendo.2009.149Search in Google Scholar

4. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med, 2001, 344, 655-664.10.1056/NEJM200103013440907Search in Google Scholar

5. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13, 114-11.10.1016/S0952-7915(00)00191-6Search in Google Scholar

6. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med, 2011, 17, 610-617.10.1038/nm.2353Search in Google Scholar

7. Turner R, Stratton I, Horton V, et al. UK Prospective Diabetes Study Group. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997, 350, 1288-1293.10.1016/S0140-6736(97)03062-6Search in Google Scholar

8. Brooks-Worrell B, Narla R, Palmer JP. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes Metab, 2013, 15(Suppl. 3), 137-140.10.1111/dom.12167426053424003930Search in Google Scholar

9. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med, 2009,15, 930-939.10.1038/nm.2002311575219633656Search in Google Scholar

10. Strissel KJ, DeFuria J, Shaul ME еt al. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity, 2010,18, 1918-1925.10.1038/oby.2010.1289425820111012Search in Google Scholar

11. Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology, 2013, 145, 366-374.10.1053/j.gastro.2013.04.010375648123597726Search in Google Scholar

12. McLaughlin T, Liu LF, Lamendola C, et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol, 2014,34, 2637-2643.10.1161/ATVBAHA.114.304636444597125341798Search in Google Scholar

13. Butcher MJ, Hallinger D, Garcia E, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia, 2014, 57, 491-501.10.1007/s00125-013-3116-5396621024429578Search in Google Scholar

14. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011,11, 98-107.10.1038/nri292521233852Search in Google Scholar

15. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia, 2001, 44, 914–92210.1007/s00125010054811508279Search in Google Scholar

16. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetesq 1999, 48, 150-7.10.2337/diabetes.48.1.1509892237Search in Google Scholar

17. Diagnosis and Classification of Diabetes Mellitus. Diabetes, Care, 2011, 34(Suppl 1), 62-69.10.2337/dc11-S062300605121193628Search in Google Scholar

18. Thomas G. Pickering, MD et al. Recomendation for blood pressure measurment in humans and experimental animals, Hypertension, 2004, 45, 142.10.1161/01.HYP.0000150859.47929.8e15611362Search in Google Scholar

19. Haider K. Zaidan, Israa H. Ibrahim, Ali H. Al Saadi, Mufeed J.Ewadh, Qasim M. Ali Al Ameri Total and differential leukocytes count in type 2 diabetes mellitus patients in Iraq. Research in Biotechnology, 2012, 3(2)1, 32-40.Search in Google Scholar

20. Menart- Houtermans B., Rütter R, Nowotny B et al. Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS). Diabetes Care, 2014, 37(8), 2326-2333.10.2337/dc14-031625061140Search in Google Scholar

21. Bradshaw EM, Raddassi K, Elyaman W. et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. Journal of immunology, 2009, 183, 4432-9.10.4049/jimmunol.0900576277050619748982Search in Google Scholar

22. Zak K.P., Mankovsky B.M., Kondratska I.N et al. Afanasyeva Immunity in patients with type 2 diabetes mellitus with concomitant metabolic syndrome/obesity. Communication 1. Composition of blood leukocytes, immunophenotype of lymphocytes, and ultrastructure of neutrophils. Endokrynologia, 2013, 18 (1), 27-36.Search in Google Scholar

23. Jason De Furiaa, Anna C. Belkinab, Madhumita Jagannathan-Bogdanc et al. B Cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. PANAS, 2010, 110, 5133-5138.Search in Google Scholar